Endoscopic Retrograde Cholangiopancreatography Market Size & Share, by Product (Endoscopes, Endotherapy Devices, Energy Devices); End-user (Hospitals, Ambulatory Surgery Centers) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2035

  • Report ID: 4859
  • Published Date: Apr 28, 2023
  • Report Format: PDF, PPT

Companies Dominating the Endoscopic Retrograde Cholangiopancreatography Landscape

    • Boston Scientific Corporation
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Cook Medical LLC
    • Olympus Corporation
    • Conmed Corporation
    • Medtronic plc
    • Fujifilm Holdings Corporation
    • ERBE Elektromedizin GmbH
    • Steris plc
    • Karl Storz GmbH & Co. KG
    • Ethicon Endo-Surgery, Inc.


In The News

  • Boston Scientific Corporation: Boston Scientific announced the launch of its EXALT Model D Single-Use Duodenoscope, which is the first and only FDA-cleared single-use duodenoscope on the market. The device is designed to eliminate the need for duodenoscope reprocessing and reduce the risk of infection transmission to patients.
  • Olympus Corporation: Olympus announced the launch of its PowerSpiral Endoscopic Ultrasound (EUS) system, which is designed to enhance the diagnosis of gastrointestinal (GI) disorders. The system features a rotating ultrasound transducer that provides high-resolution images of the GI tract, enabling physicians to detect small lesions and abnormalities that may have been missed with traditional EUS techniques.

Author Credits:  Radhika Gupta, Shivam Bhutani

  • Report ID: 4859
  • Published Date: Apr 28, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Increasing prevalence of pancreatic and biliary diseases, along with the growing geriatric population are the major factors driving the market growth.

The market size of endoscopic retrograde cholangiopancreatography is anticipated to attain a CAGR of ~12.60% over the forecast period, i.e., 2023-2035.

The lack of skilled healthcare professionals is estimated to be the growth hindering factor for the market expansion.

The market in the Asia Pacific region is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.

The major players in the market are Fujifilm Holdings Corporation, ERBE Elektromedizin GmbH, Steris plc, Karl Storz GmbH & Co. KG, Ethicon Endo-Surgery, Inc., and others.

The company profiles are selected based on the revenues generated from the product segment, the geographical presence of the company which determines the revenue generating capacity as well as the new products being launched into the market by the company.

The market is segmented by product, end-user, and by region.

The hospital segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.
Inquiry Before Buying Request Free Sample

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying